Analyst Ratings for CG Oncology (CGON)
CGON Rating Summary
CGON Price Target Summary
- Highest: $93.00 (Morgan Stanley)
- Lowest: $40.00 (Goldman Sachs)
- Average: $70.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$70.30 (+13.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | Wedbush | Robert Driscoll | New Coverage | Outperform (N/A) |
70.00 (N/A) |
41.74 (61.88) |
48.25% | Details |
| 11/24/2025 | Truist Securities » Updated 2/10/2026 |
Greg Renza | New Coverage | Buy (N/A) |
75.00 (66.00) |
42.44 (61.88) |
45.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
